COMBINED BACTERIAL MENINGITIS VACCINES TO BE INTRODUCED THROUGH MUCOUS MEMBRANE

摘要

FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to manufacturing of vaccines for intranasal introductions. There is offered composition to be delivered through mucous membrane, containing two or more following agents: a capsular oligosaccharide antigen which induces immune response on Haemophilus influenzae; and (b) a capsular oligosaccharide antigen which induces immune response on Neisseria meningitidis; with specified antigens conjugated with a carrier protein. ^ EFFECT: combination allows for single introduction to immunisation against two separate agents of the systemic disease, namely bacterial meningitis. ^ 20 cl, 4 dwg